Used to monitor minimal residual disease in Philadelphia chromosome positive CML or AML patients being treated with tyrosine kinase inhibitors.
Interpretive report provided
4 - 8 days
Collect specimen in lavender EDTA tube. Do not spin or aliquot. Send to Specimen Processing at room temperature.
Specimen must arrive at Versiti within 48 hours of collection
Test performed by Versiti